Hyperperfusion syndrome after intracranial angioplasty and stent placement [12]

Stroke

Volumn 37, Issue 9, 2006, Pages 2210-2211

  Meyers, Philip M ^a   Phatouros, Constantine C ^b   Higashida, Randall T ^c  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b ROYAL PERTH HOSPITAL   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; WARFARIN;

BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN DISEASE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAROTID ENDARTERECTOMY; CEREBRAL HYPERPERFUSION SYNDROME; COMPUTER ASSISTED TOMOGRAPHY; CORONARY STENT; DOPPLER ECHOGRAPHY; HUMAN; HYPERTENSION; LETTER; MEDICAL LITERATURE; NEUROIMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; VERTEBRAL ARTERY;

AGED; ANGIOPLASTY; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; HUMANS; MALE; STENTS; VERTEBROBASILAR INSUFFICIENCY;

EID: 33748369467     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000237208.77716.1c     Document Type: Letter

References (12)

1. Rezende MT, Spelle L, Mounayer C, Piotin M, Abud DG, Moret J. Hyperperfusion syndrome after stenting for intracranial vertebral stenosis. Stroke. 2006;37:e12-e14.
2. Meyers PM, Higashida RT, Phatouros CC, Malek AM, Lempert TE, Dowd CF, Halbach VV. Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries. Neurosurgery. 2000;47:335-343.
3. Kaku Y, Yoshimura S, Kokuzawa J. Factors predictive of cerebral hyperperfusion after carotid angioplasty and stent placement. AJNR Am J Neuroradiol. 2004;25:1403-1408.
4. Gossetti B, Martinelli O, Guerricchio R, Irace L, Benedetti-Valentini F. Transcranial doppler in 178 patients before, during, and after carotid endarterectomy. 1997;7:213-216.
5. Dalman JE, Beenakkers IC, Moll FL, Leusink JA, Ackerstaff RG. Transcranial doppler monitoring during carotid endarterectomy helps to identify patients at risk of postoperative hyperperfusion. Eur J Vasc Endovasc Surg. 1999;18:222-227.
6. Chimowitz MI, Kokkinos J, Strong J, Brown MB, Levine SR, Silliman S, Pessin MS, Weichel E, Sila CA, Furlan AJ. The warfarin-aspirin symptomatic intracranial disease study. Neurology. 1995;45:1488-1493.
7. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
8. Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP Jr, Jackson CM, Pullicino P. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. 2001;345:1444-1451.
9. Qureshi AI, Saad M, Zaidat OO, Suarez JI, Alexander MJ, Fareed M, Suri K, Ali Z, Hopkins LN. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke. 2002;33:1916-1919.
10. Qureshi AI, Suri MF, Ali Z, Kim SH, Lanzino G, Fessler RD, Ringer AJ, Guterman LR, Hopkins LN. Carotid angioplasty and stent placement: A prospective analysis of perioperative complications and impact of intravenously administered abciximab. Neurosurgery. 2002;50:466-473; discussion 473-465.
11. Ellis SG, Roubin GS, Wilentz J, Douglas JS Jr, King SB 3rd. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J. 1989;117:777-782.
12. Friedman HZ, Cragg DR, Glazier SM, Gangadharan V, Marsalese DL, Schreiber TL, O'Neill WW. Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplasty. J Am Coll Cardiol. 1994;24:1214-1219.